Thursday, April 08, 2010

Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies

Date Posted: 03/31/2010
Size: 6.64MB
Length: 00:14:32
Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis

In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Brand Stewardship: Best Practices for Maintaining Creative Integrity and Client Services

Date Posted: 03/29/2010
Size: 8.40MB
Length: 00:18:21
Thought Leaders: Tammy Fischer, President, GSW Worldwide in New York and Bruce Rooke, Chief Creative Officer, GSW Worldwide

In this episode, Ms. Fischer and Mr. Rooke discuss best practices for brand stewardship and how to maintain creative integrity. They cover the issues as they relate to the client, the consumer, and the agency.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Social Networking for Patient Recruitment for Clinical Trials

Date Posted: 03/18/2010
Size: 5.77MB
Length: 00:12:36
Thought Leader: Scott Connor, VP of Marketing, Acurian

In this episode, Mr. Connor describes how social networking can be used as a powerful business tool for patient recruitment for clinical trials.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Modernizing Incentive Compensation Plans

Date Posted: 03/16/2010
Size: 7.46MB
Length: 00:16:19
Thought Leader: Stephen M. Fox, Global Practice Leader, Sales Performance Center of Excellence, IMS Management Consulting

In this episode, Mr. Fox discusses incentive compensation plans in the pharmaceutical industry, why the incumbent plans aren't working, and how new solutions have emerged that improve the accuracy and efficiency of plans.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Standards for Industry-Sponsored Studies and Journal Publication Planning

Date Posted: 03/12/2010
Size: 6.53MB
Length: 00:14:16
Thought Leaders: Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal

In this episode we cover the Medical Publishing Insights and Practices (MPIP) initiative, a relatively new development co-sponsored by Amgen, AstraZeneca, GlaxoSmithKline, Pfizer and the International Society for Medical Publication Professionals (ISMPP). Ms. Mansi and Dr. Groves discuss what MPIP is, who is behind the initiative, its goals and accomplishments, and how the pharmaceutical industry and journal editors and publishers are benefitting from collaboration on standards to elevate trust and transparency in publishing industry-sponsored studies. The latest undertaking is the creation of an Authors' Submission Toolkit: A Practical Guide to Getting Your Research Published, being rolled-out at the 6th Annual Meeting of ISMPP, April 19-21, Arlington, VA. To learn more and register, please visit http://www.ismpp.org.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.